245 related articles for article (PubMed ID: 20571065)
1. Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.
Shen Q; Lee ES; Pitts RL; Wu MH; Yuan SY
Mol Cancer Res; 2010 Jul; 8(7):939-51. PubMed ID: 20571065
[TBL] [Abstract][Full Text] [Related]
2. A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier.
Kargozaran H; Yuan SY; Breslin JW; Watson KD; Gaudreault N; Breen A; Wu MH
Clin Exp Metastasis; 2007; 24(7):495-502. PubMed ID: 17653824
[TBL] [Abstract][Full Text] [Related]
3. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
Li Z; Li D; Li J; Huang P; Qin H
Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
[TBL] [Abstract][Full Text] [Related]
4. Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation.
Peyri N; Berard M; Fauvel-Lafeve F; Trochon V; Arbeille B; Lu H; Legrand C; Crepin M
Anticancer Res; 2009 Jun; 29(6):2347-55. PubMed ID: 19528501
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
Chernov AV; Sounni NE; Remacle AG; Strongin AY
J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
[TBL] [Abstract][Full Text] [Related]
6. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
7. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
Magee PJ; Allsopp P; Samaletdin A; Rowland IR
Eur J Nutr; 2014 Feb; 53(1):345-50. PubMed ID: 23568763
[TBL] [Abstract][Full Text] [Related]
8. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
9. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
Lafleur MA; Tester AM; Thompson EW
FEBS Lett; 2003 Oct; 553(3):457-63. PubMed ID: 14572669
[TBL] [Abstract][Full Text] [Related]
10. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
[TBL] [Abstract][Full Text] [Related]
13. ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
Conrad C; Götte M; Schlomann U; Roessler M; Pagenstecher A; Anderson P; Preston J; Pruessmeyer J; Ludwig A; Li R; Kamm RD; Ritz R; Carl B; Nimsky C; Bartsch JW
Int J Cancer; 2018 Feb; 142(4):779-791. PubMed ID: 28986926
[TBL] [Abstract][Full Text] [Related]
14. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
15. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
16. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
17. Individual Timp deficiencies differentially impact pro-MMP-2 activation.
English JL; Kassiri Z; Koskivirta I; Atkinson SJ; Di Grappa M; Soloway PD; Nagase H; Vuorio E; Murphy G; Khokha R
J Biol Chem; 2006 Apr; 281(15):10337-46. PubMed ID: 16469749
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
20. In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.
Paquette B; Baptiste C; Therriault H; Arguin G; Plouffe B; Lemay R
Br J Cancer; 2007 Dec; 97(11):1505-12. PubMed ID: 17987037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
